Autolus Therapeutics plc (AUTL) Reports Material Event to SEC
Filing Details Autolus Therapeutics plc (NASDAQ:AUTL) filed a Form 8-K with the Securities and Exchange Commission on August 03, 2026, disclosing a material event. Market Context…
Read more
